Articles with the keyword: 


Study finds safer, more efficient medication for hepatitis B treatment
kavin submitted, created time 6 months 1 week (esciencenews.com)
Patients with hepatitis B who did not respond to lamivudine therapy had a better virological response after switching to entecavir for a year. Continuing the drug for an additional year led to even more clinical improvement without significant side effects, according to a new study in the July issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). The article is also available online at Wiley Interscience (www.interscience.wiley.com). Chronic hepatitis B is the tenth leading cause of death worldwide 


DanyC submitted, created time 11 months 2 weeks (www.newsweek.com)
One Australian newspaper, referring to a study about an antibiotic-resistant bacterial infection affecting homosexual men in San Francisco and other American cities.
Maybe it's a big bomb in the field of "gay" infection. 


500,000 Chinese die of hepatitis B annually
BIOBOSS submitted, created time 1 year 8 months (www.bionews.in)
Beijing, April 9 - China has the world’s largest population of hepatitis B patients, said an official of the Chinese Hepatitis Prevention Foundation (HPF) here. 
\ 1
\